The findings, revealed this month in Essential Critiques in Toxicology, arrive at a crucial time for North American producers, suppliers, and regulatory stakeholders because the FDA continues its ongoing evaluation of sunscreen substances.
“For manufacturers and formulators, this evaluation additional validates avobenzone’s position as a cornerstone of broad-spectrum UV safety,” Dr. Kimberly Norman, PCPC’s senior director of security and regulatory toxicology and lead creator on the research, informed CosmeticsDesign.
Research confirms low absorption & no vital toxicity markers
The evaluation assessed each scientific and nonclinical information to judge avobenzone’s human well being danger profile, overlaying pharmacokinetics, toxicology, and real-world publicity information from human biomonitoring and regulatory databases.
The authors concluded that “avobenzone has an acceptable security profile with none clear markers of toxicity or endpoints of concern.” They discovered “no proof of avobenzone results on immune tissues or the estrogen, androgen, or thyroid programs,” and famous that the ingredient “has not proven any indication of genotoxicity both in vitro or in vivo.”
Importantly for formulators and regulatory affairs groups, dermal absorption was discovered to be low. “The scientific information point out very low percutaneous absorption in people,” at lower than 1% of the utilized dose, the authors wrote.
The evaluation established a NOAEL (no-observed-adverse-effect stage) of 450 mg/kg/day from sub-chronic oral research in rats, leading to a calculated margin of security larger than 100, which exceeds the usual thresholds for security assurance.
Findings supply readability for business and regulators
The Private Care Merchandise Council (PCPC), which sponsored the analysis, emphasised the importance of the findings for the U.S. market.
“The findings of the excellent evaluation reinforce what many years of scientific information have already proven: avobenzone is a secure and efficient sunscreen ingredient,” mentioned Dr. Norman.
“At a time when shoppers are more and more scrutinizing product security and producers are navigating evolving regulatory landscapes, the findings present readability and reassurance.”
For North American producers and suppliers, the evaluation helps continued innovation inside regulatory parameters. “Customers, producers, suppliers and different stakeholders needs to be assured within the findings of this evaluation,” Dr. Norman mentioned.
Formulation implications & and the FDA evaluation course of
In the USA, avobenzone is permitted to be used in OTC sunscreen merchandise at concentrations as much as 3%. It’s presently the one FDA-listed devoted UVA absorber within the Sunscreen Monograph, making it a foundational element of broad-spectrum solar care merchandise in the marketplace.
“This complete, weight-of-evidence analysis is supportive of the continued secure use of avobenzone,” Dr. Norman mentioned. “It reaffirms the secure use of the UV filter inside regulatory security necessities.”
The evaluation may assist information the FDA’s ongoing evaluation of sunscreen energetic substances. “The evaluation gives sturdy, science-based proof that helps its continued secure use,” she mentioned. “We hope that the analysis informs FDA’s selections by reinforcing the ingredient’s security profile and guiding future regulatory updates by means of balancing innovation with client safety.”
A possible mannequin for future ingredient opinions
The research’s methodology, which contains each conventional and non-animal testing information, could function a framework for evaluating different UV filters presently beneath regulatory scrutiny.
“Sure, this evaluation units a powerful precedent for the way UV filters and different sunscreen substances may be assessed utilizing present scientific methodologies, together with non-animal testing strategies, and clear processes,” Dr. Norman mentioned.
She added {that a} comparable strategy was used for an additional current security analysis of sunscreen ingredient ensulizole, highlighting the business’s dedication to proactive ingredient evaluation.
Supply: Essential Critiques in Toxicology, 55(6), 662–692. doi: 10.1080/10408444.2025.2535394. “Complete evaluation of avobenzone (butyl methoxydibenzoylmethane) toxicology information and human publicity evaluation for private care merchandise.” Authors: Norman, Ok. G., et al.
